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Microphthalmia-associated transcription factor (MITF), a basic-
helix-loop-helix (bHLH) and bHLH-leucine zipper transcription
factor, is currently an intense focal point in pigment cell biology
research. MITF is implicated as the master gene for survival of
melanocytes, as well as a key transcription factor regulating the
expression of major melanogenic proteins such as tyrosinase and
the tyrosinase-related proteins TRP1 and TRP2 (Goding, 2000),
via binding to a conserved consensus element, the so-called M-
box, in the promoter region of each gene (Yasumoto et al, 1997).
Mice bearing null alleles of the MITF gene display complete loss
of neural crest-derived melanocytes, deafness and a failure of ret-
inal pigment epithelium di¡erentiation (Goding, 2000). At least
two separate mechanisms mediate the diverse biological functions
of MITF. First, sustained expression of MITF appears to be
modulated through a cAMP-dependent pathway (Bertolotto
et al, 1998; Price et al, 1998); and second, MITF function is transi-
ently up-regulated via mitogen-activated protein kinase
(MAPK)-dependent phosphorylation of MITF itself (Hemesath
et al, 1998). Thus, a-melanocyte stimulating hormone (a-MSH)
and other cAMP-elevating agents transcriptionally up-regulate
the expression of MITF through a cAMP-response element
(CRE) in the MITF promoter region (Goding, 2000). In contrast,
c-kit transiently increases MITF function by a MAPK-mediated
phosphorylation of MITF which recruits p300/CBP (CREB-
binding protein), a coactivator family that in turn enhances the
transcriptional activity of MITF (Hemesath et al, 1998). More re-
cently, MITF was shown to promote survival of pigment cells by
up-regulating the expression of the major antiapoptotic protein
BCL2 (McGill et al, 2002).
In this issue of the JID, two articles further explore the role of
MITF in modulation of pigmentation. Lin and colleagues (p. 1330)
report that MITF may in part mediate UV-induced pigmentation
and that certain antioxidants reduce basal pigmentation as well as
UV-induced pigmentation in an MITF-dependent manner.
By transfecting an MITF promoter-luciferase construct into mur-
ine pigment cells, they were able to demonstrate that MITF
promoter activity is enhanced by UVB irradiation (30 mJ/cm2),
with maximal e¡ect 7^8 h after the irradiation. Their results add
MITF to the list of genes whose expression is a¡ected by UV
irradiation. The authors hypothesize that UV is not likely to en-
hance the promoter activity of MITF directly, but rather to act
indirectly through a-MSH and ACTH, which is released from
the same propeptide and binds the same receptor as a-MSH. Gi-
ven that UV increases production of these hormones by keratino-
cytes (Wintzen et al, 1996) and that a-MSH is known to induce
MITF gene transcription (Bertolotto et al, 1998; Price et al, 1998), it
is indeed likely that UV-induced a-MSH mediates an increased
MITF transcription in vivo. However, in the experimental model
system employed, a monolayer of pigment cells were transfected
with an MITF promoter-luciferase construct. Thus, UV would
¢rst need to up-regulate MSH in these cells, which is not yet de-
monstrated. Further, a-MSH is known to induce MITF tran-
scription by elevating the intracellular level of cAMP, yet the
authors report that UVB irradiation did not increase the intracel-
lular level of cAMP in their experiments. Therefore, one must
consider the possibility that UV irradiation up-regulates MITF
expression through an alternative pathway yet to be elucidated.
Lin et al further found that the antioxidants dihydrolipoic acid
(DHLA), lipoic acid (LA) and reservatrol (RES) decreased MITF
promoter activity and protein levels, as well as tyrosinase protein
level and activity (JID). Other antioxidants, such as ascorbic acid
and glutathione, did not have these e¡ects. However, one appar-
ently contradictory recent report, not discussed by the authors,
suggests that the level of MITF is down-regulated by oxidative
stress (Jimenez-Cervantes et al, 2001), and that oxidative stress
transiently down-regulates the expression of tyrosinase, TRP-1
and TRP-2 in an MITF-dependent manner (Jimenez-Cervantes
et al, 2001).These apparent discrepancies will need to be examined
in future experiments.
To explore the in vivo relevance of their ¢ndings, the authors
topically applied DHLA, LA and RES on dark-skinned Yucatan
swine with or without UV irradiation expected to tan the skin.
Topical application of all three agents lightened both basal and
UV-induced skin pigmentation. Therefore, the authors suggested
that modulation of pigmentation can be achieved through redu-
cing or enhancing MITF activity in vivo. Although intriguing,
this approach will need to be pursued with caution, given MITF
is involved in not only melanogenesis but in the long term is also
critical to survival of normal and healthy melanocytes (Goding,
2000).
In the second paper, Lei and colleagues (p. 1341) report induc-
tion of pigmentation by 8-methoxypsoralen (8MOP) in the ab-
sence of UV and examine possible mechanisms. Employing an
immortalized murine melanocyte line as a model system, the
authors ask whether MITF, the cAMP-dependent protein kinase
(PKA) and/or protein kinase C (PKC) pathways, as well as pro-
teasome-mediated degradation of tyrosinase might play a role in
8MOP-induced pigmentation.They treated cells with 8MOP, the
PKA activator foreskolin, or the PKC activator 1-oleoyl-2-acety-
glycerol (OAG) for 6 days and observed an increase in tyrosinase
activity and melanin in all except in OAG-treated cells.Then pre-
sumptively speci¢c inhibitors for PKA and for PKC were em-
ployed to determine if the 8MOP-induced increase in
pigmentation utilizes one or both of these pathways. The authors
conclude that while PKA inhibition blocks 8MOP-induced in-
creases in tyrosinase protein and activity, as well as in total mela-
nin content, PKC inhibition had no e¡ect. However, their Fig 4
shows that the PKC inhibitor clearly blocks the 8MOP-induced
increase in melanin content to the same extent as the PKA inhi-
bitor, although by day 6 (when measurements were ¢rst made)
there was no e¡ect on tyrosinase activity. Since changes in mela-
nin level are subsequent to changes in tyrosinase activity, these
results are compatible with the PKC pathway playing an impor-
tant role prior to day 6, for example by activating pre-existing
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tyrosinase protein, as reported by our group (Park et al, 1999).
Time course studies would be of interest in further exploring
the role of the PKC-dependent pathway in 8MOP-induced pig-
mentation. A ¢nal caveat: Despite the e¡orts of these authors and
the others whose work they cite to examine 8MOP in isolation,
it is extremely di⁄cult to exclude the possibility that minute
amounts of incidental UVA irradiation did photoactivate this ex-
quisitely sensitive compound. Their ¢ndings would then pertain
to pigmentation-induced by PUVA rather than by 8MOP.
Much is yet to be learned about MITF, the presumptive master
gene for pigment cells. The fact that MITF is now recognized to
be a family of at least ¢ve isoforms (Shibahara et al, 2001) suggests
considerable complexity for the biological function of this tran-
scription factor. The two articles in this JID issue provide further
insight into how MITF mediates pigmentation as the regulatory
protein for many di¡erent agents.
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